Skip to main content
Top
Published in: BMC Neurology 1/2019

Open Access 01-12-2019 | Cerebral Small Vessel Disease | Research article

High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population

Authors: Ki-Woong Nam, Hyung-Min Kwon, Han-Yeong Jeong, Jin-Ho Park, Hyuktae Kwon, Su-Min Jeong

Published in: BMC Neurology | Issue 1/2019

Login to get access

Abstract

Background

Triglycerides (TG)/high-density lipoprotein (HDL) cholesterol ratio is a marker of small/dense low-density lipoprotein particles, which are closely associated with various metabolic and vascular diseases. However, the role of TG/HDL cholesterol ratio in cerebrovascular diseases has not been well studied. In this study, we evaluated the relationship between TG/HDL cholesterol ratio and the presence of silent brain infarct (SBI) in a neurologically healthy population.

Methods

We retrospectively evaluated consecutive participants in health check-ups between January 2006 and December 2013. SBI was defined as an asymptomatic, well-defined lesion with a diameter of ≥3 mm on T1- or T2-weighted images. TG/HDL cholesterol ratio was calculated after dividing absolute TG levels by absolute HDL cholesterol levels.

Results

Of 3172 healthy participants, 263 (8.3%) had SBI lesions. In multivariate analysis, TG/HDL cholesterol ratio was independently associated with SBI (adjusted odds ratio [aOR] = 1.16, 95% confidence interval [CI] = 1.00 to 1.34, P = 0.047). This association was prominent in males (aOR = 1.23, 95% CI = 1.03 to 1.48, P = 0.021), but not in females. In the analyses of the relationships between lipid parameters and SBI lesion burden, TG/HDL cholesterol ratio was positively correlated, and total cholesterol/TG ratio was negatively correlated with SBI lesion burden, in dose-response manners (P for trend = 0.015 and 0.002, respectively).

Conclusions

The TG/HDL cholesterol ratio was positively associated with the prevalence of SBI in a neurologically healthy population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.CrossRef Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38.CrossRef
2.
go back to reference Kim BJ, Lee S-H. Prognostic impact of cerebral small vessel disease on stroke outcome. J Stroke. 2015;17(2):101.CrossRef Kim BJ, Lee S-H. Prognostic impact of cerebral small vessel disease on stroke outcome. J Stroke. 2015;17(2):101.CrossRef
3.
go back to reference Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener H-C. Assessment of functioning and disability after ischemic stroke. Stroke. 2002;33(8):2053–9.CrossRef Weimar C, Kurth T, Kraywinkel K, Wagner M, Busse O, Haberl RL, Diener H-C. Assessment of functioning and disability after ischemic stroke. Stroke. 2002;33(8):2053–9.CrossRef
4.
go back to reference Inoue K, Matsumoto M, Shono T, Toyokawa S, Moriki A. Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis. 2007;16(1):14–20.CrossRef Inoue K, Matsumoto M, Shono T, Toyokawa S, Moriki A. Increased intima media thickness and atherosclerotic plaques in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis. 2007;16(1):14–20.CrossRef
5.
go back to reference Hassan A, Hunt BJ, O’sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126(2):424–32.CrossRef Hassan A, Hunt BJ, O’sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain. 2003;126(2):424–32.CrossRef
6.
go back to reference Wardlaw J. Blood-brain barrier and cerebral small vessel disease. J Neurol Sci. 2010;299(1–2):66–71.CrossRef Wardlaw J. Blood-brain barrier and cerebral small vessel disease. J Neurol Sci. 2010;299(1–2):66–71.CrossRef
7.
go back to reference Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110.CrossRef Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110.CrossRef
8.
go back to reference Bang O, Saver J, Liebeskind D, Pineda S, Ovbiagele B. Association of serum lipid indices with large artery atherosclerotic stroke. Neurology. 2008;70(11):841–7.CrossRef Bang O, Saver J, Liebeskind D, Pineda S, Ovbiagele B. Association of serum lipid indices with large artery atherosclerotic stroke. Neurology. 2008;70(11):841–7.CrossRef
9.
go back to reference PLd L, Favarato D, Faria-Neto Junior JR, Lemos P, Chagas ACP. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics. 2008;63(4):427–32. PLd L, Favarato D, Faria-Neto Junior JR, Lemos P, Chagas ACP. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics. 2008;63(4):427–32.
10.
go back to reference Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23(11):1679–85.CrossRef Boizel R, Benhamou PY, Lardy B, Laporte F, Foulon T, Halimi S. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care. 2000;23(11):1679–85.CrossRef
11.
go back to reference Cabrera MAS, de Andrade SM, Mesas AE. A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging. 2012;7:463.CrossRef Cabrera MAS, de Andrade SM, Mesas AE. A prospective study of risk factors for cardiovascular events among the elderly. Clin Interv Aging. 2012;7:463.CrossRef
12.
go back to reference Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873–80.CrossRef Frohlich J, Dobiášová M. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem. 2003;49(11):1873–80.CrossRef
13.
go back to reference Yoshida A, Kouwaki M, Matsutani Y, Fukuchi Y, Naito M. Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence of small, dense LDL. J Atheroscler Thromb. 2004;11(4):215–9.CrossRef Yoshida A, Kouwaki M, Matsutani Y, Fukuchi Y, Naito M. Usefulness of serum total cholesterol/triglyceride ratio for predicting the presence of small, dense LDL. J Atheroscler Thromb. 2004;11(4):215–9.CrossRef
15.
go back to reference Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97(7):1007–9.CrossRef Bhalodkar NC, Blum S, Enas EA. Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians. Am J Cardiol. 2006;97(7):1007–9.CrossRef
16.
go back to reference Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583–8.CrossRef Dobiásová M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein-depleted plasma (FERHDL). Clin Biochem. 2001;34(7):583–8.CrossRef
17.
go back to reference Pacifico L, Bonci E, Andreoli G, Romaggioli S, Di Miscio R, Lombardo C, Chiesa C. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr Metab Cardiovasc Dis. 2014;24(7):737–43.CrossRef Pacifico L, Bonci E, Andreoli G, Romaggioli S, Di Miscio R, Lombardo C, Chiesa C. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents. Nutr Metab Cardiovasc Dis. 2014;24(7):737–43.CrossRef
18.
go back to reference Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Maciel PM, Reaven GM. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio. Am J Med. 2014;127(2):152–7.CrossRef Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Maciel PM, Reaven GM. Identification of cardiometabolic risk: visceral adiposity index versus triglyceride/HDL cholesterol ratio. Am J Med. 2014;127(2):152–7.CrossRef
19.
go back to reference Hermans MP, Ahn SA, Rousseau MF. The atherogenic dyslipidemia ratio [log (TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis. 2012;11(1):132.CrossRef Hermans MP, Ahn SA, Rousseau MF. The atherogenic dyslipidemia ratio [log (TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids Health Dis. 2012;11(1):132.CrossRef
20.
go back to reference Lamarche B, Després J-P, Moorjani S, Cantin B, Dagenais GR, Lupien P-J. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis. 1996;119(2):235–45.CrossRef Lamarche B, Després J-P, Moorjani S, Cantin B, Dagenais GR, Lupien P-J. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Quebec cardiovascular study. Atherosclerosis. 1996;119(2):235–45.CrossRef
21.
go back to reference Deng QW, Wang H, Sun CZ, Xing FL, Zhang HQ, Zuo L, Gu ZT, Yan FL. Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke. Eur J Neurol. 2017;24(2):283–91.CrossRef Deng QW, Wang H, Sun CZ, Xing FL, Zhang HQ, Zuo L, Gu ZT, Yan FL. Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke. Eur J Neurol. 2017;24(2):283–91.CrossRef
22.
go back to reference Nam K-W, Kwon H-M, Jeong H-Y, Park J-H, Kim SH, Jeong S-M, Yoo TG, Kim S. Cerebral white matter hyperintensity is associated with intracranial atherosclerosis in a healthy population. Atherosclerosis. 2017;265:179–83.CrossRef Nam K-W, Kwon H-M, Jeong H-Y, Park J-H, Kim SH, Jeong S-M, Yoo TG, Kim S. Cerebral white matter hyperintensity is associated with intracranial atherosclerosis in a healthy population. Atherosclerosis. 2017;265:179–83.CrossRef
23.
go back to reference Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ, Kargman DE, Sacco RL, Wityk RJ, Ford G, Fayad PB, for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial: final results, Neurology. 1995;45(8):1488–93.CrossRef Chimowitz MI, Kokkinos J, Strong J, Brown MB, Levine SR, Silliman S, Pessin MS, Weichel E, Sila CA, Furlan AJ, Kargman DE, Sacco RL, Wityk RJ, Ford G, Fayad PB, for the Warfarin-Aspirin Symptomatic Intracranial Disease Study Group. Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Trial: final results, Neurology. 1995;45(8):1488–93.CrossRef
24.
go back to reference O'meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164(12):1313–8.CrossRef O'meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164(12):1313–8.CrossRef
25.
go back to reference Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko G. The TG/HDL cholesterol ratio predicts all cause mortality in women with suspected myocardial ischemia a report from the Women’s ischemia syndrome evaluation (WISE). Am Heart J. 2009;157(3):548.CrossRef Bittner V, Johnson BD, Zineh I, Rogers WJ, Vido D, Marroquin OC, Bairey-Merz CN, Sopko G. The TG/HDL cholesterol ratio predicts all cause mortality in women with suspected myocardial ischemia a report from the Women’s ischemia syndrome evaluation (WISE). Am Heart J. 2009;157(3):548.CrossRef
26.
go back to reference Mazza A, Tikhonoff V, Schiavon L, Casiglia E. Triglycerides+ high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J. 2005;35(10):604–10.CrossRef Mazza A, Tikhonoff V, Schiavon L, Casiglia E. Triglycerides+ high-density-lipoprotein-cholesterol dyslipidaemia, a coronary risk factor in elderly women: the CArdiovascular STudy in the ELderly. Intern Med J. 2005;35(10):604–10.CrossRef
27.
go back to reference Freiberg JJ, Tybjærg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. Jama. 2008;300(18):2142–52.CrossRef Freiberg JJ, Tybjærg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. Jama. 2008;300(18):2142–52.CrossRef
28.
go back to reference Varbo A, Nordestgaard BG, Tybjærg-Hansen A, Schnohr P, Jensen GB, Benn M. Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population. Ann Neurol. 2011;69(4):628–34.CrossRef Varbo A, Nordestgaard BG, Tybjærg-Hansen A, Schnohr P, Jensen GB, Benn M. Nonfasting triglycerides, cholesterol, and ischemic stroke in the general population. Ann Neurol. 2011;69(4):628–34.CrossRef
29.
go back to reference Masson W, Siniawski D, Lobo M, Molinero G, Huerín M. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women. Endocrinol Nutr. 2016;63(7):327–32.CrossRef Masson W, Siniawski D, Lobo M, Molinero G, Huerín M. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women. Endocrinol Nutr. 2016;63(7):327–32.CrossRef
30.
go back to reference Masley SC, Roetzheim R, Masley LV, McNamara T, Schocken DD. Emerging risk factors as markers for carotid intima media thickness scores. J Am Coll Nutr. 2015;34(2):100–7.CrossRef Masley SC, Roetzheim R, Masley LV, McNamara T, Schocken DD. Emerging risk factors as markers for carotid intima media thickness scores. J Am Coll Nutr. 2015;34(2):100–7.CrossRef
31.
go back to reference Shishehbor MH, Hoogwerf BJ, Lauer MS. Association of triglyceride–to–HDL cholesterol ratio with heart rate recovery. Diabetes Care. 2004;27(4):936–41.CrossRef Shishehbor MH, Hoogwerf BJ, Lauer MS. Association of triglyceride–to–HDL cholesterol ratio with heart rate recovery. Diabetes Care. 2004;27(4):936–41.CrossRef
32.
go back to reference González-Chávez A, Simental-Mendía LE, Elizondo-Argueta S. Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance. Cir Cir. 2011;79(2):126–31.PubMed González-Chávez A, Simental-Mendía LE, Elizondo-Argueta S. Elevated triglycerides/HDL-cholesterol ratio associated with insulin resistance. Cir Cir. 2011;79(2):126–31.PubMed
33.
go back to reference Lee JE, Shin DW, Yun JM, Kim SH, Nam Y-S, Cho B, Lim J-S, Jeong H-Y, Kwon H-M, Park J-H. Insulin resistance is a risk factor for silent lacunar infarction. Stroke. 2016;47(12):2938–44.CrossRef Lee JE, Shin DW, Yun JM, Kim SH, Nam Y-S, Cho B, Lim J-S, Jeong H-Y, Kwon H-M, Park J-H. Insulin resistance is a risk factor for silent lacunar infarction. Stroke. 2016;47(12):2938–44.CrossRef
34.
go back to reference Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Avraham SB. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care. 2012;35(3):640–7.CrossRef Golan R, Shelef I, Rudich A, Gepner Y, Shemesh E, Chassidim Y, Harman-Boehm I, Henkin Y, Schwarzfuchs D, Avraham SB. Abdominal superficial subcutaneous fat: a putative distinct protective fat subdepot in type 2 diabetes. Diabetes Care. 2012;35(3):640–7.CrossRef
Metadata
Title
High triglyceride/HDL cholesterol ratio is associated with silent brain infarcts in a healthy population
Authors
Ki-Woong Nam
Hyung-Min Kwon
Han-Yeong Jeong
Jin-Ho Park
Hyuktae Kwon
Su-Min Jeong
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2019
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-019-1373-8

Other articles of this Issue 1/2019

BMC Neurology 1/2019 Go to the issue